Abstract
We read with interest the innovative study by Bustamante et al.1 that focuses on the prognostic role of ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) in recanalization of acute ischemic stroke. Beyond limitations already noted by the authors, important issues need to be further discussed.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have